Thematic Review Series: Functional Regulation of Lipid Homeostasis by microRNA: Complexity of microRNA function and the role of isomiRs in lipid homeostasis

Journal of Lipid Research

Volumn 54, Issue 5, 2013, Pages 1182-1191

  Vickers, Kasey C ^a,b   Sethupathy, Praveen ^a,c   Baran Gale, Jeanette ^c   Remaley, Alan T ^d  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Lipid metabolism; MicroRNA isoform; Nontemplated additions

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN LIKE 3; ARGONAUTE 2 PROTEIN; GLYCEROL 3 PHOSPHATE ACYLTRANSFERASE; MICRORNA; MICRORNA 27B; OXIDIZED LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RNA ISOFORM; RNA POLYMERASE II; SMALL INTERFERING RNA; SMALL UNTRANSLATED RNA; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; CELL PROLIFERATION; CHOLESTEROL DIET; DNA FRAGMENTATION; FATTY ACID OXIDATION; HOMEOSTASIS; HUMAN; LIPID HOMEOSTASIS; LIPID METABOLISM; LIPOPROTEIN SYNTHESIS; LIVER CELL; METABOLIC REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; REVIEW; RNA ANALYSIS; RNA SEQUENCE; RNA SPLICING; RNA STABILITY; RNA TRANSCRIPTION; CLASSIFICATION; GENE EXPRESSION REGULATION; GENETIC VARIABILITY; GENETICS; LIVER; METABOLISM;

GENE EXPRESSION REGULATION; GENETIC VARIATION; HOMEOSTASIS; HUMANS; LIPID METABOLISM; LIVER; MICRORNAS;

EID: 84876812092     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.R034801     Document Type: Review

References (139)

1. Jump, D. B. 2011. Fatty acid regulation of hepatic lipid metabolism. Curr. Opin. Clin. Nutr. Metab. Care. 14 : 115-120.
2. Tessari, P., A. Coracina, A. Cosma, and A. Tiengo. 2009. Hepatic lipid metabolism and non-alcoholic fatty liver disease. Nutr. Metab. Cardiovasc. Dis. 19 : 291-302.
3. Bauer, R. C., I. M. Stylianou, and D. J. Rader. 2011. Functional validation of new pathways in lipoprotein metabolism identified by human genetics. Curr. Opin. Lipidol. 22 : 123-128.
4. Kei, A. A., T. D. Filippatos, V. Tsimihodimos, and M. S. Elisaf. 2012. A review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular disease. Metabolism. 61 : 906-921.
5. Hassing, H. C., R. P. Surendran, H. L. Mooij, E. S. Stroes, M. Nieuwdorp, and G. M. Dallinga-Thie. 2012. Pathophysiology of hypertriglyceridemia. Biochim. Biophys. Acta. 1821 : 826-832.
6. Bou Khalil, M., A. Blais, D. Figeys, and Z. Yao. 2010. Lipin-the bridge between hepatic glycerolipid biosynthesis and lipoprotein metabolism. Biochim. Biophys. Acta. 1801 : 1249-1259.
7. Flamment, M., J. Rieusset, H. Vidal, G. Simard, Y. Malthiery, B. Fromenty, and P. H. Ducluzeau. 2012. Regulation of hepatic mitochondrial metabolism in response to a high fat diet: A longitudinal study in rats. J. Physiol. Biochem. 68 : 335-344.
8. Worthington, H., S. E. Olpin, I. Blumenthal, and A. A. Morris. 2007. Hyperlipidaemia due to carnitine palmitoyltransferase I deficiency. J. Inherit. Metab. Dis. 30 : 104.
9. Otarod, J. K., and I. J. Goldberg. 2004. Lipoprotein lipase and its role in regulation of plasma lipoproteins and cardiac risk. Curr. Atheroscler. Rep. 6 : 335-342.
10. Lomb, D. J., G. Laurent, and M. C. Haigis. 2010. Sirtuins regulate key aspects of lipid metabolism. Biochim. Biophys. Acta. 1804 : 1652-1657.
11. Quiroga, A. D., and R. Lehner. 2012. Liver triacylglycerol lipases. Biochim. Biophys. Acta. 1821 : 762-769.
12. Picard, F., M. Kurtev, N. Chung, A. Topark-Ngarm, T. Senawong, R. Machado De Oliveira, M. Leid, M. W. McBurney, and L. Guarente. 2004. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature. 429 : 771-776.
13. Parkes, H. A., E. Preston, D. Wilks, M. Ballesteros, L. Carpenter, L. Wood, E. W. Kraegen, S. M. Furler, and G. J. Cooney. 2006. Overexpression of acyl-CoA synthetase-1 increases lipid deposition in hepatic (HepG2) cells and rodent liver in vivo. Am. J. Physiol. Endocrinol. Metab. 291 : E737-E744.
14. Mendez-Gonzalez, J., J. Julve, N. Rotllan, G. Llaverias, F. Blanco-Vaca, and J. C. Escola-Gil. 2011. ATP-binding cassette G5/G8 deficiency causes hypertriglyceridemia by affecting multiple metabolic pathways. Biochim. Biophys. Acta. 1811 : 1186-1193.
15. Bishop, J. R., K. I. Stanford, and J. D. Esko. 2008. Heparan sulfate proteoglycans and triglyceride-rich lipoprotein metabolism. Curr. Opin. Lipidol. 19 : 307-313.
16. Zhang, W., P. G. Yancey, Y. R. Su, V. R. Babaev, Y. Zhang, S. Fazio, and M. F. Linton. 2003. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice. Circulation. 108 : 2258-2263.
17. Johansen, C. T., and R. A. Hegele. 2011. Genetic bases of hypertriglyceridemic phenotypes. Curr. Opin. Lipidol. 22 : 247-253.
18. Wang, B., N. Moya, S. Niessen, H. Hoover, M. M. Mihaylova, R. J. Shaw, J. R. Yates 3rd, W. H. Fischer, J. B. Thomas, and M. Montminy. 2011. A hormone-dependent module regulating energy balance. Cell. 145 : 596-606.
19. Sun, Z., R. A. Miller, R. T. Patel, J. Chen, R. Dhir, H. Wang, D. Zhang, M. J. Graham, T. G. Unterman, G. I. Shulman, et al. 2012. Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration. Nat. Med. 18 : 934-942.
20. Lindberg, D. A. 2009. Acute pancreatitis and hypertriglyceridemia. Gastroenterol. Nurs. 32: 75-82; quiz 83-74.
21. Puri, P., M. M. Wiest, O. Cheung, F. Mirshahi, C. Sargeant, H. K. Min, M. J. Contos, R. K. Sterling, M. Fuchs, H. Zhou, et al. 2009. The plasma lipidomic signature of nonalcoholic steatohepatitis. Hepatology. 50 : 1827-1838.
22. Musso, G., R. Gambino, and M. Cassader. 2013. Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis. Prog. Lipid Res. 52: 175-191.
23. Ling, J., J. Lewis, D. Douglas, N. M. Kneteman, and D. E. Vance. 2013. Characterization of lipid and lipoprotein metabolism in primary human hepatocytes. Biochim. Biophys. Acta. 1831 : 387-397.
24. Donnelly, K. L., C. I. Smith, S. J. Schwarzenberg, J. Jessurun, M. D. Boldt, and E. J. Parks. 2005. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Invest. 115 : 1343-1351.
25. Bensinger, S. J., and P. Tontonoz. 2008. Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature. 454 : 470-477.
26. van Bilsen, M., G. J. van der Vusse, A. J. Gilde, M. Lindhout, and K. A. van der Lee. 2002. Peroxisome proliferator-activated receptors: Lipid binding proteins controling gene expression. Mol. Cell. Biochem. 239 : 131-138.
27. Calkin, A. C., and P. Tontonoz. 2012. Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR. Nat. Rev. Mol. Cell Biol. 13 : 213-224.
28. Jump, D. B., D. Botolin, Y. Wang, J. Xu, B. Christian, and O. Demeure. 2005. Fatty acid regulation of hepatic gene transcription. J. Nutr. 135 : 2503-2506.
29. Odom, D. T., N. Zizlsperger, D. B. Gordon, G. W. Bell, N. J. Rinaldi, H. L. Murray, T. L. Volkert, J. Schreiber, P. A. Rolfe, D. K. Gifford, et al. 2004. Control of pancreas and liver gene expression by HNF transcription factors. Science. 303 : 1378-1381.
30. Zhang, C., G. Wang, Z. Zheng, K. R. Maddipati, X. Zhang, G. Dyson, P. Williams, S. A. Duncan, R. J. Kaufman, and K. Zhang. 2012. Endoplasmic reticulum-tethered transcription factor cAMP responsive element-binding protein, hepatocyte specific, regulates hepatic lipogenesis, fatty acid oxidation, and lipolysis upon metabolic stress in mice. Hepatology. 55 : 1070-1082.
31. Wang, N. D., M. J. Finegold, A. Bradley, C. N. Ou, S. V. Abdelsayed, M. D. Wilde, L. R. Taylor, D. R. Wilson, and G. J. Darlington. 1995. Impaired energy homeostasis in C/EBP alpha knockout mice. Science. 269 : 1108-1112.
32. Inoue, Y., J. Inoue, G. Lambert, S. H. Yim, and F. J. Gonzalez. 2004. Disruption of hepatic C/EBPalpha results in impaired glucose tolerance and age-dependent hepatosteatosis. J. Biol. Chem. 279 : 44740-44748.
33. Wolfrum, C., E. Asilmaz, E. Luca, J. M. Friedman, and M. Stoffel. 2004. Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes. Nature. 432 : 1027-1032.
34. Matsumoto, M., S. Han, T. Kitamura, and D. Accili. 2006. Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism. J. Clin. Invest. 116 : 2464-2472.
35. Kousteni, S. 2012. FoxO1, the transcriptional chief of staff of energy metabolism. Bone. 50 : 437-443.
36. Brown, M. S., and J. L. Goldstein. 1998. Sterol regulatory element binding proteins (SREBPs): Controllers of lipid synthesis and cellular uptake. Nutr. Rev. 56: S1-S3; discussion S54-S75.
37. Horton, J. D., Y. Bashmakov, I. Shimomura, and H. Shimano. 1998. Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice. Proc. Natl. Acad. Sci. USA. 95 : 5987-5992.
38. Horton, J. D., and I. Shimomura. 1999. Sterol regulatory elementbinding proteins: Activators of cholesterol and fatty acid biosynthesis. Curr. Opin. Lipidol. 10 : 143-150.
39. Horton, J. D. 2002. Sterol regulatory element-binding proteins: Transcriptional activators of lipid synthesis. Biochem. Soc. Trans. 30 : 1091-1095.
40. Esau, C., S. Davis, S. F. Murray, X. X. Yu, S. K. Pandey, M. Pear, L. Watts, S. L. Booten, M. Graham, R. McKay, et al. 2006. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 3 : 87-98.
41. Iliopoulos, D., K. Drosatos, Y. Hiyama, I. J. Goldberg, and V. I. Zannis. 2010. MicroRNA-370 controls the expression of micro-RNA-122 and Cpt1alpha and affects lipid metabolism. J. Lipid Res. 51 : 1513-1523.
42. Whittaker, R., P. A. Loy, E. Sisman, E. Suyama, P. Aza-Blanc, R. S. Ingermanson, J. H. Price, and P. M. McDonough. 2010. Identification of MicroRNAs that control lipid droplet formation and growth in hepatocytes via high-content screening. J. Biomol. Screen. 15 : 798-805.
43. Rayner, K. J., C. Fernandez-Hernando, and K. J. Moore. 2012. MicroRNAs regulating lipid metabolism in atherogenesis. Thromb. Haemost. 107 : 642-647.
44. Moore, K. J., K. J. Rayner, Y. Suarez, and C. Fernandez-Hernando. 2011. The role of microRNAs in cholesterol efflux and hepatic lipid metabolism. Annu. Rev. Nutr. 31 : 49-63.
45. Fernandez-Hernando, C., Y. Suarez, K. J. Rayner, and K. J. Moore. 2011. MicroRNAs in lipid metabolism. Curr. Opin. Lipidol. 22 : 86-92.
46. Rayner, K. J., F. J. Sheedy, C. C. Esau, F. N. Hussain, R. E. Temel, S. Parathath, J. M. van Gils, A. J. Rayner, A. N. Chang, Y. Suarez, et al. 2011. Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. J. Clin. Invest. 121 : 2921-2931.
47. Herrera-Merchan, A., C. Cerrato, G. Luengo, O. Dominguez, M. A. Piris, M. Serrano, and S. Gonzalez. 2010. miR-33-mediated downregulation of p53 controls hematopoietic stem cell self-renewal. Cell Cycle. 9 : 3277-3285.
48. Marquart, T. J., R. M. Allen, D. S. Ory, and A. Baldan. 2010. miR-33 links SREBP-2 induction to repression of sterol transporters. Proc. Natl. Acad. Sci. USA. 107 : 12228-12232.
49. Rayner, K. J., Y. Suarez, A. Davalos, S. Parathath, M. L. Fitzgerald, N. Tamehiro, E. A. Fisher, K. J. Moore, and C. Fernandez-Hernando. 2010. MiR-33 contributes to the regulation of cholesterol homeostasis. Science. 328 : 1570-1573.
50. Najafi-Shoushtari, S. H., F. Kristo, Y. Li, T. Shioda, D. E. Cohen, R. E. Gerszten, and A. M. Naar. 2010. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science. 328 : 1566-1569.
51. Branch, A. D., and C. M. Rice. 2010. Antisense gets a grip on miR-122 in chimpanzees. Sci. Transl. Med. 2 : 13ps11.
52. Hildebrandt-Eriksen, E. S., V. Aarup, R. Persson, H. F. Hansen, M. E. Munk, and H. Orum. 2012. A locked nucleic acid oligonucleotide targeting microRNA 122 is well-tolerated in cynomolgus monkeys. Nucleic Acid Ther. 22: 152-161.
53. Haussecker, D., and M. A. Kay. 2010. miR-122 continues to blaze the trail for microRNA therapeutics. Mol. Ther. 18 : 240-242.
54. Vickers, K. C., and A. T. Remaley. 2012. Lipid-based carriers of microRNAs and intercellular communication. Curr. Opin. Lipidol. 23 : 91-97.
55. Rayner, K. J., C. C. Esau, F. N. Hussain, A. L. McDaniel, S. M. Marshall, J. M. van Gils, T. D. Ray, F. J. Sheedy, L. Goedeke, X. Liu, et al. 2011. Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature. 478 : 404-407.
56. Bartel, D. P. 2004. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 116 : 281-297.
57. Bartel, D. P. 2009. MicroRNAs: Target recognition and regulatory functions. Cell. 136 : 215-233.
58. Grimson, A., M. Srivastava, B. Fahey, B. J. Woodcroft, H. R. Chiang, N. King, B. M. Degnan, D. S. Rokhsar, and D. P. Bartel. 2008. Early origins and evolution of microRNAs and Piwi-interacting RNAs in animals. Nature. 455 : 1193-1197.
59. Kim, V. N., J. Han, and M. C. Siomi. 2009. Biogenesis of small RNAs in animals. Nat. Rev. Mol. Cell Biol. 10 : 126-139.
60. Esteller, M. 2011. Non-coding RNAs in human disease. Nat. Rev. Genet. 12 : 861-874.
61. Burroughs, A. M., Y. Ando, M. J. de Hoon, Y. Tomaru, H. Suzuki, Y. Hayashizaki, and C. O. Daub. 2011. Deep-sequencing of human Argonaute-associated small RNAs provides insight into miRNA sorting and reveals Argonaute association with RNA fragments of diverse origin. RNA Biol. 8 : 158-177.
62. Ender, C., A. Krek, M. R. Friedlander, M. Beitzinger, L. Weinmann, W. Chen, S. Pfeffer, N. Rajewsky, and G. Meister. 2008. A human snoRNA with microRNA-like functions. Mol. Cell. 32 : 519-528.
63. Taft, R. J., E. A. Glazov, T. Lassmann, Y. Hayashizaki, P. Carninci, and J. S. Mattick. 2009. Small RNAs derived from snoRNAs. RNA. 15 : 1233-1240.
64. Okamura, K., and E. C. Lai. 2008. Endogenous small interfering RNAs in animals. Nat. Rev. Mol. Cell Biol. 9 : 673-678.
65. Nolte-'t Hoen, E. N., H. P. Buermans, M. Waasdorp, W. Stoorvogel, M. H. Wauben, and P. A. 't Hoen. 2012. Deep sequencing of RNA from immune cell-derived vesicles uncovers the selective incorporation of small non-coding RNA biotypes with potential regulatory functions. Nucleic Acids Res. 40 : 9272-9285.
66. Persson, H., A. Kvist, J. Vallon-Christersson, P. Medstrand, A. Borg, and C. Rovira. 2009. The non-coding RNA of the multidrug resistance-linked vault particle encodes multiple regulatory small RNAs. Nat. Cell Biol. 11 : 1268-1271.
67. Taft, R. J., E. A. Glazov, N. Cloonan, C. Simons, S. Stephen, G. J. Faulkner, T. Lassmann, A. R. Forrest, S. M. Grimmond, K. Schroder, et al. 2009. Tiny RNAs associated with transcription start sites in animals. Nat. Genet. 41 : 572-578.
68. Taft, R. J., C. D. Kaplan, C. Simons, and J. S. Mattick. 2009. Evolution, biogenesis and function of promoter-associated RNAs. Cell Cycle. 8 : 2332-2338.
69. Lee, Y. S., Y. Shibata, A. Malhotra, and A. Dutta. 2009. A novel class of small RNAs: TRNA-derived RNA fragments (tRFs). Genes Dev. 23 : 2639-2649.
70. Baek, D., J. Villen, C. Shin, F. D. Camargo, S. P. Gygi, and D. P. Bartel. 2008. The impact of microRNAs on protein output. Nature. 455 : 64-71.
71. Kozomara, A., and S. Griffiths-Jones. 2011. miRBase: Integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 39 : D152-D157.
72. Kim, V. N. 2005. MicroRNA biogenesis: Coordinated cropping and dicing. Nat. Rev. Mol. Cell Biol. 6 : 376-385.
73. Grimson, A., K. K. Farh, W. K. Johnston, P. Garrett-Engele, L. P. Lim, and D. P. Bartel. 2007. MicroRNA targeting specificity in mammals: Determinants beyond seed pairing. Mol. Cell. 27 : 91-105.
74. Borchert, G. M., W. Lanier, and B. L. Davidson. 2006. RNA polymerase III transcribes human microRNAs. Nat. Struct. Mol. Biol. 13 : 1097-1101.
75. Chong, M. M., G. Zhang, S. Cheloufi, T. A. Neubert, G. J. Hannon, and D. R. Littman. 2010. Canonical and alternate functions of the microRNA biogenesis machinery. Genes Dev. 24 : 1951-1960.
76. Ladewig, E., K. Okamura, A. S. Flynt, J. O. Westholm, and E. C. Lai. 2012. Discovery of hundreds of mirtrons in mouse and human small RNA data. Genome Res. 22 : 1634-1645.
77. Sibley, C. R., Y. Seow, S. Saayman, K. K. Dijkstra, S. El Andaloussi, M. S. Weinberg, and M. J. Wood. 2012. The biogenesis and characterization of mammalian microRNAs of mirtron origin. Nucleic Acids Res. 40 : 438-448.
78. Westholm, J. O., and E. C. Lai. 2011. Mirtrons: MicroRNA biogenesis via splicing. Biochimie. 93 : 1897-1904.
79. Cheloufi, S., C. O. Dos Santos, M. M. Chong, and G. J. Hannon. 2010. A dicer-independent miRNA biogenesis pathway that requires Ago catalysis. Nature. 465 : 584-589.
80. Cifuentes, D., H. Xue, D. W. Taylor, H. Patnode, Y. Mishima, S. Cheloufi, E. Ma, S. Mane, G. J. Hannon, N. D. Lawson, et al. 2010. A novel miRNA processing pathway independent of Dicer requires Argonaute2 catalytic activity. Science. 328 : 1694-1698.
81. Yang, J. S., T. Maurin, N. Robine, K. D. Rasmussen, K. L. Jeffrey, R. Chandwani, E. P. Papapetrou, M. Sadelain, D. O'Carroll, and E. C. Lai. 2010. Conserved vertebrate mir-451 provides a platform for Dicer-independent, Ago2-mediated microRNA biogenesis. Proc. Natl. Acad. Sci. USA. 107 : 15163-15168.
82. Gerin, I., L. A. Clerbaux, O. Haumont, N. Lanthier, A. K. Das, C. F. Burant, I. A. Leclercq, O. A. MacDougald, and G. T. Bommer. 2010. Expression of miR-33 from an SREBP2 intron inhibits cholesterol export and fatty acid oxidation. J. Biol. Chem. 285 : 33652-33661.
83. Elmen, J., M. Lindow, S. Schutz, M. Lawrence, A. Petri, S. Obad, M. Lindholm, M. Hedtjarn, H. F. Hansen, U. Berger, et al. 2008. LNA-mediated microRNA silencing in non-human primates. Nature. 452 : 896-899.
84. Cirera-Salinas, D., M. Pauta, R. M. Allen, A. G. Salerno, C. M. Ramirez, A. Chamorro-Jorganes, A. C. Wanschel, M. A. Lasuncion, M. Morales-Ruiz, Y. Suarez, et al. 2012. Mir-33 regulates cell proliferation and cell cycle progression. Cell Cycle. 11 : 922-933.
85. Vickers, K. C., B. M. Shoucri, M. G. Levin, H. Wu, D. S. Pearson, D. Osei-Hwedieh, F. S. Collins, A. T. Remaley, and P. Sethupathy. 2013. MicroRNA-27b is a regulatory hub in lipid metabolism and is altered in dyslipidemia. Hepatology. 57: 533-542.
86. Conklin, D., D. Gilbertson, D. W. Taft, M. F. Maurer, T. E. Whitmore, D. L. Smith, K. M. Walker, L. H. Chen, S. Wattler, M. Nehls, et al. 1999. Identification of a mammalian angiopoietin-related protein expressed specifically in liver. Genomics. 62 : 477-482.
87. Koishi, R., Y. Ando, M. Ono, M. Shimamura, H. Yasumo, T. Fujiwara, H. Horikoshi, and H. Furukawa. 2002. Angptl3 regulates lipid metabolism in mice. Nat. Genet. 30 : 151-157.
88. MacArthur, J. M., J. R. Bishop, K. I. Stanford, L. Wang, A. Bensadoun, J. L. Witztum, and J. D. Esko. 2007. Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members. J. Clin. Invest. 117 : 153-164.
89. Gonzalez-Baro, M. R., T. M. Lewin, and R. A. Coleman. 2007. Regulation of triglyceride metabolism. II. Function of mitochondrial GPAT1 in the regulation of triacylglycerol biosynthesis and insulin action. Am. J. Physiol. Gastrointest. Liver Physiol. 292 : G1195-G1199.
90. Xu, H., D. Wilcox, P. Nguyen, M. Voorbach, T. Suhar, S. J. Morgan, W. F. An, L. Ge, J. Green, Z. Wu, et al. 2006. Hepatic knockdown of mitochondrial GPAT1 in ob/ob mice improves metabolic profile. Biochem. Biophys. Res. Commun. 349 : 439-448.
91. Teslovich, T. M., K. Musunuru, A. V. Smith, A. C. Edmondson, I. M. Stylianou, M. Koseki, J. P. Pirruccello, S. Ripatti, D. I. Chasman, C. J. Willer, et al. 2010. Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 466 : 707-713.
92. Liu, J., H. Afroza, D. J. Rader, and W. Jin. 2010. Angiopoietinlike protein 3 inhibits lipoprotein lipase activity through enhancing its cleavage by proprotein convertases. J. Biol. Chem. 285 : 27561-27570.
93. Shimizugawa, T., M. Ono, M. Shimamura, K. Yoshida, Y. Ando, R. Koishi, K. Ueda, T. Inaba, H. Minekura, T. Kohama, et al. 2002. ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase. J. Biol. Chem. 277 : 33742-33748.
94. Sacco, J., and K. Adeli. 2012. MicroRNAs: Emerging roles in lipid and lipoprotein metabolism. Curr. Opin. Lipidol. 23 : 220-225.
95. Lee, E. K., M. J. Lee, K. Abdelmohsen, W. Kim, M. M. Kim, S. Srikantan, J. L. Martindale, E. R. Hutchison, H. H. Kim, B. S. Marasa, et al. 2011. miR-130 suppresses adipogenesis by inhibiting peroxisome proliferator-activated receptor gamma expression. Mol. Cell. Biol. 31 : 626-638.
96. Wang, B., S. H. Hsu, W. Frankel, K. Ghoshal, and S. T. Jacob. 2012. Stat3-mediated activation of microRNA-23a suppresses gluconeogenesis in hepatocellular carcinoma by down-regulating glucose-6-phosphatase and peroxisome proliferatoractivated receptor gamma, coactivator 1 alpha. Hepatology. 56 : 186-197.
97. Ou, Z., T. Wada, R. Gramignoli, S. Li, S. C. Strom, M. Huang, and W. Xie. 2011. MicroRNA hsa-miR-613 targets the human LXRalpha gene and mediates a feedback loop of LXRalpha autoregulation. Mol. Endocrinol. 25 : 584-596.
98. Zheng, L., G. C. Lv, J. Sheng, and Y. D. Yang. 2010. Effect of miRNA-10b in regulating cellular steatosis level by targeting PPARalpha expression, a novel mechanism for the pathogenesis of NAFLD. J. Gastroenterol. Hepatol. 25 : 156-163.
99. Kida, K., M. Nakajima, T. Mohri, Y. Oda, S. Takagi, T. Fukami, and T. Yokoi. 2011. PPARalpha is regulated by miR-21 and miR-27b in human liver. Pharm. Res. 28 : 2467-2476.
100. Zhou, J., W. Ju, D. Wang, L. Wu, X. Zhu, Z. Guo, and X. He. 2012. Down-regulation of microRNA-26a promotes mouse hepatocyte proliferation during liver regeneration. PLoS ONE. 7 : E33577.
101. Chen, H., Y. Sun, R. Dong, S. Yang, C. Pan, D. Xiang, M. Miao, and B. Jiao. 2011. Mir-34a is upregulated during liver regeneration in rats and is associated with the suppression of hepatocyte proliferation. PLoS ONE. 6 : E20238.
102. Laudadio, I., I. Manfroid, Y. Achouri, D. Schmidt, M. D. Wilson, S. Cordi, L. Thorrez, L. Knoops, P. Jacquemin, F. Schuit, et al. 2012. A feedback loop between the liver-enriched transcription factor network and miR-122 controls hepatocyte differentiation. Gastroenterology. 142 : 119-129.
103. Moore, K. J., K. J. Rayner, Y. Suarez, and C. Fernandez-Hernando. 2010. microRNAs and cholesterol metabolism. Trends Endocrinol. Metab. 21 : 699-706.
104. Niu, Y., D. Mo, L. Qin, C. Wang, A. Li, X. Zhao, X. Wang, S. Xiao, Q. Wang, Y. Xie, et al. 2011. Lipopolysaccharide-induced miR-1224 negatively regulates tumour necrosis factor-alpha gene expression by modulating Sp1. Immunology. 133 : 8-20.
105. Kojima, S., T. F. Kuo, H. Tatsukawa, and S. Hirose. 2010. Induction of cross-linking and silencing of Sp1 by transglutaminase during liver injury in ASH and NASH via different ER stress pathways. Dig. Dis. 28 : 715-721.
106. Li, L., S. He, J. M. Sun, and J. R. Davie. 2004. Gene regulation by Sp1 and Sp3. Biochem. Cell Biol. 82: 460-471.
107. Sekar, N., and J. D. Veldhuis. 2004. Involvement of Sp1 and SREBP-1a in transcriptional activation of the LDL receptor gene by insulin and LH in cultured porcine granulosa-luteal cells. Am. J. Physiol. Endocrinol. Metab. 287 : E128-E135.
108. Alisi, A., L. Da Sacco, G. Bruscalupi, F. Piemonte, N. Panera, R. De Vito, S. Leoni, G. F. Bottazzo, A. Masotti, and V. Nobili. 2011. Mirnome analysis reveals novel molecular determinants in the pathogenesis of diet-induced nonalcoholic fatty liver disease. Lab. Invest. 91 : 283-293.
109. Cheung, O., P. Puri, C. Eicken, M. J. Contos, F. Mirshahi, J. W. Maher, J. M. Kellum, H. Min, V. A. Luketic, and A. J. Sanyal. 2008. Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression. Hepatology. 48 : 1810-1820.
110. Khaidakov, M., S. Mitra, X. Wang, Z. Ding, N. Bora, V. Lyzogubov, F. Romeo, S. A. Schichman, and J. L. Mehta. 2012. Large impact of low concentration oxidized LDL on angiogenic potential of human endothelial cells: A microarray study. PLoS ONE. 7 : E47421.
111. Guo, L., H. Li, T. Liang, J. Lu, Q. Yang, Q. Ge, and Z. Lu. 2012. Consistent isomiR expression patterns and 3 ′ addition events in miRNA gene clusters and families implicate functional and evolutionary relationships. Mol. Biol. Rep. 39 : 6699-6706.
112. Neilsen, C. T., G. J. Goodall, and C. P. Bracken. 2012. IsomiRs-the overlooked repertoire in the dynamic microRNAome. Trends Genet. 28 : 544-549.
113. Cloonan, N., S. Wani, Q. Xu, J. Gu, K. Lea, S. Heater, C. Barbacioru, A. L. Steptoe, H. C. Martin, E. Nourbakhsh, et al. 2011. MicroRNAs and their isomiRs function cooperatively to target common biological pathways. Genome Biol. 12 : R126.
114. Polikepahad, S., and D. B. Corry. 2013. Profi ling of T helper cellderived small RNAs reveals unique antisense transcripts and differential association of miRNAs with argonaute proteins 1 and 2. Nucl. Acids Res. 41: 1164-1177.
115. Azuma-Mukai, A., H. Oguri, T. Mituyama, Z. R. Qian, K. Asai, H. Siomi, and M. C. Siomi. 2008. Characterization of endogenous human Argonautes and their miRNA partners in RNA silencing. Proc. Natl. Acad. Sci. USA. 105 : 7964-7969.
116. Humphreys, D. T., C. J. Hynes, H. R. Patel, G. H. Wei, L. Cannon, D. Fatkin, C. M. Suter, J. L. Clancy, and T. Preiss. 2012. Complexity of murine cardiomyocyte miRNA biogenesis, sequence variant expression and function. PLoS ONE. 7 : E30933.
117. Alon, S., E. Mor, F. Vigneault, G. M. Church, F. Locatelli, F. Galeano, A. Gallo, N. Shomron, and E. Eisenberg. 2012. Systematic identification of edited microRNAs in the human brain. Genome Res. 22 : 1533-1540.
118. Blow, M. J., R. J. Grocock, S. van Dongen, A. J. Enright, E. Dicks, P. A. Futreal, R. Wooster, and M. R. Stratton. 2006. RNA editing of human microRNAs. Genome Biol. 7 : R27.
119. Nishikura, K. 2010. Functions and regulation of RNA editing by ADAR deaminases. Annu. Rev. Biochem. 79 : 321-349.
120. Reid, J. G., A. K. Nagaraja, F. C. Lynn, R. B. Drabek, D. M. Muzny, C. A. Shaw, M. K. Weiss, A. O. Naghavi, M. Khan, H. Zhu, et al. 2008. Mouse let-7 miRNA populations exhibit RNA editing that is constrained in the 5 ′-seed/cleavage/anchor regions and stabilize predicted mmu-let-7a:mRNA duplexes. Genome Res. 18 : 1571-1581.
121. Kawahara, Y., B. Zinshteyn, P. Sethupathy, H. Iizasa, A. G. Hatzigeorgiou, and K. Nishikura. 2007. Redirection of silencing targets by adenosine-to-inosine editing of miRNAs. Science. 315 : 1137-1140.
122. Katoh, T., Y. Sakaguchi, K. Miyauchi, T. Suzuki, S. Kashiwabara, T. Baba, and T. Suzuki. 2009. Selective stabilization of mammalian microRNAs by 3 ′ adenylation mediated by the cytoplasmic poly(A) polymerase GLD-2. Genes Dev. 23 : 433-438.
123. Pritchard, C. C., H. H. Cheng, and M. Tewari. 2012. MicroRNA profi ling: Approaches and considerations. Nat. Rev. Genet. 13 : 358-369.
124. Lee, L. W., S. Zhang, A. Etheridge, L. Ma, D. Martin, D. Galas, and K. Wang. 2010. Complexity of the microRNA repertoire revealed by next-generation sequencing. RNA. 16 : 2170-2180.
125. Wyman, S. K., E. C. Knouf, R. K. Parkin, B. R. Fritz, D. W. Lin, L. M. Dennis, M. A. Krouse, P. J. Webster, and M. Tewari. 2011. Post-transcriptional generation of miRNA variants by multiple nucleotidyl transferases contributes to miRNA transcriptome complexity. Genome Res. 21 : 1450-1461.
126. Kim, Y. K., I. Heo, and V. N. Kim. 2010. Modifications of small RNAs and their associated proteins. Cell. 143 : 703-709.
127. Shimakami, T., D. Yamane, R. K. Jangra, B. J. Kempf, C. Spaniel, D. J. Barton, and S. M. Lemon. 2012. Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex. Proc. Natl. Acad. Sci. USA. 109 : 941-946.
128. Jangra, R. K., M. Yi, and S. M. Lemon. 2010. Regulation of hepatitis C virus translation and infectious virus production by the microRNA miR-122. J. Virol. 84 : 6615-6625.
129. Fornari, F., L. Gramantieri, C. Giovannini, A. Veronese, M. Ferracin, S. Sabbioni, G. A. Calin, G. L. Grazi, C. M. Croce, S. Tavolari, et al. 2009. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res. 69 : 5761-5767.
130. Zeng, C., R. Wang, D. Li, X. J. Lin, Q. K. Wei, Y. Yuan, Q. Wang, W. Chen, and S. M. Zhuang. 2010. A novel GSK-3 beta-C/EBP alphamiR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma. Hepatology. 52 : 1702-1712.
131. Zeisel, M. B., S. Pfeffer, and T. F. Baumert. miR-122 acts as a tumor suppressor in hepatocarcinogenesis in vivo. J. Hepatol. Epub ahead of print. October 17, 2012; doi:10.1016/j.jhep.2012.10.010.
132. Hu, J., Y. Xu, J. Hao, S. Wang, C. Li, and S. Meng. 2012. MiR-122 in hepatic function and liver diseases. Protein Cell. 3: 364-371.
133. Tsai, W. C., S. D. Hsu, C. S. Hsu, T. C. Lai, S. J. Chen, R. Shen, Y. Huang, H. C. Chen, C. H. Lee, T. F. Tsai, et al. 2012. MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J. Clin. Invest. 122 : 2884-2897.
134. Wen, J., and J. R. Friedman. 2012. miR-122 regulates hepatic lipid metabolism and tumor suppression. J. Clin. Invest. 122 : 2773-2776.
135. Ding, X., J. Ding, J. Ning, F. Yi, J. Chen, D. Zhao, J. Zheng, Z. Liang, Z. Hu, and Q. Du. 2012. Circulating microRNA-122 as a potential biomarker for liver injury. Mol. Med. Rep. 5: 1428-1432.
136. Xu, J., C. Wu, X. Che, L. Wang, D. Yu, T. Zhang, L. Huang, H. Li, W. Tan, C. Wang, et al. 2011. Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. Mol. Carcinog. 50 : 136-142.
137. Bala, S., J. Petrasek, S. Mundkur, D. Catalano, I. Levin, J. Ward, H. Alao, K. Kodys, and G. Szabo. 2012. Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases. Hepatology. 56 : 1946-1957.
138. Hsu, S. H., B. Wang, J. Kota, J. Yu, S. Costinean, H. Kutay, L. Yu, S. Bai, K. La Perle, R. R. Chivukula, et al. 2012. Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. J. Clin. Invest. 122 : 2871-2883.
139. Jones, M. R., L. J. Quinton, M. T. Blahna, J. R. Neilson, S. Fu, A. R. Ivanov, D. A. Wolf, and J. P. Mizgerd. 2009. Zcchc11-dependent uridylation of microRNA directs cytokine expression. Nat. Cell Biol. 11 : 1157-1163.